CN115177612A - A composition with hair growth promoting effect - Google Patents
A composition with hair growth promoting effect Download PDFInfo
- Publication number
- CN115177612A CN115177612A CN202210917373.XA CN202210917373A CN115177612A CN 115177612 A CN115177612 A CN 115177612A CN 202210917373 A CN202210917373 A CN 202210917373A CN 115177612 A CN115177612 A CN 115177612A
- Authority
- CN
- China
- Prior art keywords
- composition
- component
- dihydromyricetin
- theanine
- hair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 60
- 230000003779 hair growth Effects 0.000 title claims abstract description 25
- 230000001737 promoting effect Effects 0.000 title claims abstract description 23
- KJXSIXMJHKAJOD-LSDHHAIUSA-N (+)-dihydromyricetin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC(O)=C(O)C(O)=C1 KJXSIXMJHKAJOD-LSDHHAIUSA-N 0.000 claims abstract description 82
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical group CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims abstract description 70
- KQILIWXGGKGKNX-UHFFFAOYSA-N dihydromyricetin Natural products OC1C(=C(Oc2cc(O)cc(O)c12)c3cc(O)c(O)c(O)c3)O KQILIWXGGKGKNX-UHFFFAOYSA-N 0.000 claims abstract description 41
- 229940026510 theanine Drugs 0.000 claims abstract description 35
- 239000000843 powder Substances 0.000 claims abstract description 15
- 239000000419 plant extract Substances 0.000 claims abstract description 6
- 239000003826 tablet Substances 0.000 claims description 59
- 235000013616 tea Nutrition 0.000 claims description 15
- 235000020334 white tea Nutrition 0.000 claims description 12
- 241000196324 Embryophyta Species 0.000 claims description 11
- 241001018563 Nekemias grossedentata Species 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- -1 spirit Substances 0.000 claims description 4
- 235000020338 yellow tea Nutrition 0.000 claims description 3
- 235000008584 Hovenia dulcis Nutrition 0.000 claims description 2
- 244000010000 Hovenia dulcis Species 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims 2
- 230000002708 enhancing effect Effects 0.000 claims 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- 210000004209 hair Anatomy 0.000 abstract description 40
- 201000004384 Alopecia Diseases 0.000 abstract description 29
- 231100000360 alopecia Toxicity 0.000 abstract description 23
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 12
- 230000001575 pathological effect Effects 0.000 abstract description 5
- 230000003676 hair loss Effects 0.000 abstract description 4
- 208000024963 hair loss Diseases 0.000 abstract description 4
- 208000004631 alopecia areata Diseases 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 description 19
- 229920002472 Starch Polymers 0.000 description 16
- 235000019698 starch Nutrition 0.000 description 16
- 239000008107 starch Substances 0.000 description 16
- 241001122767 Theaceae Species 0.000 description 14
- 239000000284 extract Substances 0.000 description 11
- 239000003814 drug Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 230000001965 increasing effect Effects 0.000 description 10
- 235000012054 meals Nutrition 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 235000013399 edible fruits Nutrition 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 8
- 238000007873 sieving Methods 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 5
- 241000563984 Ampelopsis Species 0.000 description 4
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 210000004761 scalp Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000003778 catagen phase Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 208000001840 Dandruff Diseases 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 241000405414 Rehmannia Species 0.000 description 2
- 235000007215 black sesame Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 244000132619 red sage Species 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 229940113931 theanine 50 mg Drugs 0.000 description 2
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 description 1
- 241000427159 Achyranthes Species 0.000 description 1
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 description 1
- 244000236521 Bupleurum rotundifolium Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 240000000425 Chaenomeles speciosa Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 244000241463 Cullen corylifolium Species 0.000 description 1
- 240000007371 Cuscuta campestris Species 0.000 description 1
- 244000286838 Eclipta prostrata Species 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 241001289529 Fallopia multiflora Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 241000212322 Levisticum officinale Species 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000760198 Russula vinosa Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 235000002911 Salvia sclarea Nutrition 0.000 description 1
- 244000182022 Salvia sclarea Species 0.000 description 1
- 241001180876 Saposhnikovia Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 240000003243 Thuja occidentalis Species 0.000 description 1
- 235000008109 Thuja occidentalis Nutrition 0.000 description 1
- 241001533104 Tribulus terrestris Species 0.000 description 1
- 241000121220 Tricholoma matsutake Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 description 1
- 240000000038 Ziziphus mauritiana Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000001772 cananga odorata hook. f. and thomas. oil Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940104640 chinese yam extract Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000003741 hair volume Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 239000001645 levisticum officinale Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000001738 pogostemon cablin oil Substances 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 230000003797 telogen phase Effects 0.000 description 1
- 229940069506 theanine 100 mg Drugs 0.000 description 1
- 208000037911 visceral disease Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a composition with hair growth promoting effect, which contains a component A or a component A and a component B, wherein the component A is dihydromyricetin or a plant extract containing dihydromyricetin or powder obtained by crushing a plant containing dihydromyricetin, and the component B is theanine or a plant extract containing theanine or powder obtained by crushing a plant containing theanine; the component A and the component B are respectively 10-100 parts of component A and 0-100 parts of component B in parts by mass of dihydromyricetin and theanine. The dihydromyricetin and the theanine are combined, so that the hair conditioner can effectively regulate qi and blood, nourish hair, prevent hair loss, and has the functions of hair care and hair increase on pathological alopecia (alopecia areata and seborrheic alopecia). The composition has simple composition, convenient use and high safety, can be used for a long time, and is particularly suitable for treating pathological alopecia.
Description
Technical Field
The invention relates to a composition, in particular to a composition with a hair-increasing effect.
Background
After the hair grows to a certain degree in the growth period, the hair enters the catagen and the rest period, normal physiological shedding occurs, the hair in the growth period and the catagen is in dynamic balance, and the normal hair volume is maintained. If the hair growth homeostasis is disrupted and the amount of hair in the anagen phase is less than that in the catagen and telogen phases, the hair gradually thins, even becomes bald, called non-physiological alopecia. The non-physiological alopecia includes pathological alopecia (alopecia areata, seborrheic alopecia, etc.) and drug-induced alopecia (radiotherapy and chemotherapy alopecia).
For the treatment of alopecia, chemical medicines have the defects of side effects with different degrees and easy relapse after medicine withdrawal, and the adoption of Chinese herbal medicine components can avoid corresponding problems. The Chinese medicine literature of ancient and modern times is different in the typing of the reasons of alopecia, and the like have analyzed the related literatures of alopecia in the analysis of the Chinese medicine symptoms and the prescription rules of alopecia and white hair (J. Chinese medicine, 2016, 31 (9): 3785-3788), and there are 27 kinds of alopecia and white hair syndromes in total, wherein liver and kidney deficiency, qi stagnation and blood stasis, liver qi stagnation, heart and liver blood deficiency, damp-heat accumulation, qi and blood deficiency, blood heat, spleen deficiency and excessive dampness, kidney essence deficiency and essence and blood deficiency occur more than 10 times frequently, and 6 visceral disease sites are summarized from the syndromes, namely liver, kidney, heart, spleen, stomach and gallbladder. The traditional Chinese medicine theory considers that the main reasons of alopecia are as follows: deficiency of liver and kidney and impairment of spleen and stomach lead to deficiency of qi and blood or emotional disorder to cause qi stagnation and blood stasis, and hair is lost due to malnutrition. Therefore, the traditional Chinese medicine for treating alopecia mainly adopts the treatment principles of liver cultivation, kidney tonifying, qi and blood benefiting, blood circulation activating, blood stasis removing and the like. The Chinese medicinal composition is prepared from fleece-flower root, chinese angelica, prepared rehmannia root, szechuan lovage rhizome, glossy privet fruit, indian buead, south dodder seed, barbary wolfberry fruit, raw rehmannia root, yerbadetajo herb, white paeony root, danshen root, membranous milkvetch root, liquoric root, mulberry, largehead atractylodes rhizome, red paeony root, black sesame, arborvitae tops, safflower, pilose asiabell root, tree peony bark, oriental waterplantain rhizome, chinese date, chinese thorowax root, common floweringquince fruit, malaytea scurfpea fruit, incised notopterygium rhizome, divaricate saposhnikovia root, hawthorn fruit, twotooth achyranthes root, puncturevine caltrop fruit, chrysanthemum, honey-fried licorice root, peach seed, common macrocarpium fruit and siberian solomonseal rhizome in sequence according to the use frequency.
At present, the prior relevant hair increasing patents adopting the Chinese herbal medicines comprise: application No. 201010033855.6A composition with hair blackening and hair increasing effects comprises Aloe, semen Fagopyri Esculenti, polygoni Multiflori radix, and citric acid; application No. 201410513367.3, publication No. CN104187707A, a health food with hair growth promoting effect, which comprises buckwheat, tryptophan, methionine, isoleucine, tricholoma matsutake, russula vinosa, black sesame, black bean, polygonum multiflorum, black fungus, honeysuckle and red date; application number 201810356135.X and publication number 108379192A relate to a hair-increasing shampoo, which is composed of cortex dictamni, a conditioner, beer, cacumen biotae, water, a Chinese yam extract, a salvia miltiorrhiza extract and a rose extract. There are also some medicines which adopt other components, such as application No. 201510065971.9, publication No. CN104666995A, a medicine for treating alopecia and having hair growth promoting effect, mainly comprising crude salt, water extract of cake after oil extraction of oil tea fruit, product of alcohol fermentation and acetic acid fermentation of glutinous rice and oil extracted from fruit of Theaceae plants; application No. 201910968748.3, publication No. CN110585046A an anti-dandruff, anti-dandruff and anti-alopecia component and product, containing salicylic acid or salicylic acid derivatives; application No. 201610808247.5, publication No. 107456406A, an oily scalp hair-blackening essential oil comprises rosemary oil, geranium essential oil, lavender essential oil, lignum Santali albi oil, cananga oil, lemon oil, eucalyptus essential oil, patchouli oil, clary sage essential oil, and jojoba oil.
Disclosure of Invention
The invention aims to solve the technical problem of providing a novel composition with hair-increasing effect, and the hair-increasing effect is safe and reliable.
In order to solve the technical problems, the invention discloses a composition with hair growth promoting effect, which comprises a component A or a component A and a component B, wherein the component A is dihydromyricetin or a plant extract containing dihydromyricetin or powder of a crushed plant containing dihydromyricetin, the component B is theanine or a plant extract containing theanine or powder of a crushed plant containing theanine,
the component A and the component B are respectively 10-100 parts of component A and 0-100 parts of component B in parts by mass of dihydromyricetin and theanine.
Further, the component A and the component B are respectively 50-100 parts of the component A and 20-100 parts of the component B according to the mass parts of dihydromyricetin and theanine.
Further, the plant containing dihydromyricetin is ampelopsis grossedentata or hovenia dulcis thunb, and is preferably ampelopsis grossedentata.
Further, the plants containing theanine are albino tea, yellow tea, and BAOJING HUANG tea, wherein the albino tea is selected from Anji white tea and Jiande white tea; the yellow tea is LONGYONGHUANG tea, JINYUNHUANG tea, and NINGBOHUANG tea; the Anji white tea is preferably selected from whitening tea.
Further, the composition also comprises pharmaceutically acceptable auxiliary materials.
Further, the composition is any one of powder, tablet, capsule, pill, dripping pill, spirit, suspension, aqua, cream and ointment.
Further, the composition is a tablet.
Further, the composition is a capsule.
The dihydromyricetin used in the invention has the functions of protecting liver and kidney, benefiting qi and nourishing blood; the theanine has effects of regulating emotion and resolving stagnation of liver-qi, and can be used for effectively regulating qi and blood, nourishing hair, preventing hair loss, and caring and increasing hair for pathological alopecia (alopecia areata and seborrheic alopecia). The dihydromyricetin is mainly derived from plants with high content of dihydromyricetin such as Ampelopsis grossedentata or semen Hoveniae, and can also be derived from chemical synthesis; theanine is mainly derived from high theanine content tea such as albino tea, etiolated tea, etc., and can also be derived from chemical synthesis and microbial synthesis. The composition has simple composition, convenient use and high safety, can be used for a long time, and is particularly suitable for treating pathological alopecia. Can be made into various dosage forms for oral administration or external application.
Drawings
FIG. 1 is a graph showing a comparison of hair conditions before and after half a year when tablets of the composition obtained in example 3 were administered in accordance with example 8.
Detailed Description
The present invention will be further explained with reference to examples. The following examples are provided only for illustrating the present invention and are not intended to limit the scope of the present invention.
Example 1
A composition tablet with hair growth promoting effect prepared from purified dihydromyricetin and theanine
Tablet composition, in 1000 tablets:
composition (I) | Weights (g) |
Dihydromyricetin (purity 98%) | 102 |
Theanine (purity 40%) | 250 |
Starch | 148 |
(1) Crushing and sieving: crushing starch, and sieving with a 65-mesh sieve;
(2) Mixing: placing dihydromyricetin and theanine in a mixer, mixing for 5min, adding the sieved starch in step (1), and mixing for 10min;
(3) And (3) granulating: granulating by using a dry granulating machine;
(4) Tabletting: and (3) tabletting the granulated composition to obtain the composition tablet with the hair increasing effect.
The above tablet contains dihydromyricetin 100mg and theanine 100mg per tablet 0.5 g.
The using method comprises the following steps: twice a day in the morning and at night, two tablets are taken each time with meals.
Example 2
A composition tablet with hair growth promoting effect prepared from purified dihydromyricetin and theanine
The composition of the tablets is calculated by 1000 tablets.
Composition (A) | Weight (g) |
Dihydromyricetin (purity 98%) | 122 |
Theanine (purity 40%) | 200 |
Starch | 178 |
(1) Crushing and sieving: pulverizing starch, and sieving with 65 mesh sieve;
(2) Mixing: placing dihydromyricetin and theanine in a mixer, mixing for 5min, adding sieved starch in step (1), and mixing for 10min;
(3) And (3) granulating: granulating by using a dry-method granulator;
(4) Tabletting: and (3) tabletting the granulated composition to obtain the tablet with the hair increasing effect.
The above tablet contains dihydromyricetin 120mg and theanine 80mg per tablet 0.5 g.
The using method comprises the following steps: twice a day in the morning and at night, two tablets are taken each time with meals.
Example 3
Composition tablet with hair growth promoting effect
The composition of the tablets is calculated by 1000 tablets.
Composition (I) | Weight (g) |
Ampelopsis grossedentata extract (dihydromyricetin content 50%) | 160 |
Anji white tea extract (theanine content 20%) | 250 |
Starch | 90 |
(1) Crushing and sieving: crushing starch, and sieving with a 65-mesh sieve;
(2) Mixing: placing Ampelopsis Grossdentata extract and Anji white tea extract in a mixer, mixing for 5min, adding sieved starch in step (1), and mixing for 10min;
(3) Granulating: granulating by using a dry-method granulator;
(4) Tabletting: obtaining the tablet with hair-increasing effect.
The above tablet contains dihydromyricetin 80mg and theanine 50mg per tablet 0.5 g.
The using method comprises the following steps: twice a day in the morning and at night, two tablets are taken each time with meals.
Example 4
Composition tablet with hair growth promoting effect
The composition of the tablets is calculated by 1000 tablets.
Composition (I) | Weights (g) |
Semen Hoveniae extract (dihydromyricetin content 40%) | 200 |
Anji white tea extract (theanine content 20%) | 250 |
Starch | 50 |
(1) Crushing and sieving: pulverizing starch, and sieving with 65 mesh sieve;
(2) Mixing: mixing Ampelopsis grossedentata extract and Anji white tea extract in a mixer for 5min, adding the sieved starch in step (1), and mixing for 10min;
(3) And (3) granulating: granulating by using a dry granulating machine;
(4) Tabletting: and (3) tabletting the granulated composition to obtain the tablet with the hair-increasing effect.
The above tablet contains dihydromyricetin 80mg and theanine 50mg per tablet 0.5 g.
The using method comprises the following steps: twice a day, two tablets each time, and taken with meal.
Example 5
A preparation method of tablet with hair growth promoting effect comprises pulverizing raw materials, and making into powder
The composition of the tablets is calculated by 1000 tablets.
Composition (I) | Weight (g) |
Vine tea powder (grain size 80 mesh, 20% dihydromyricetin content) | 250 |
Anji white tea powder (particle size 80 mesh, theanine content 4%) | 250 |
(1) Mixing: mixing pulverized powder of Ampelopsis Grossdentata and Anji white tea in a mixer for 5min;
(2) And (3) granulating: granulating by using a dry granulating machine;
(3) Tabletting: tabletting the granulated composition to obtain the tablet with the hair increasing effect;
the above tablet contains dihydromyricetin 50mg and theanine 10mg per tablet 0.5 g.
The using method comprises the following steps: taken with meals three times a day, two tablets each time.
Example 6
Composition tablet with hair growth promoting effect prepared from pulverized raw materials
The composition of the tablets is calculated by 1000 tablets.
Composition (A) | Weights (g) |
Vine tea powder (grain size 100 mesh, 25% dihydromyricetin content) | 200 |
Anji white tea powder (particle size 100 mesh, theanine content 4%) | 250 |
Starch | 50 |
(1) Mixing: mixing pulverized Ampelopsis Grossdentata and Anji white tea in a mixer for 5min; adding starch, and mixing for 10min;
(2) Granulating: granulating by using a dry granulating machine;
(3) Tabletting: tabletting the granulated composition to obtain the tablet with the hair increasing effect;
each tablet contains 0.5g of dihydromyricetin 50mg and theanine 10mg.
The using method comprises the following steps: the composition is taken with meal, three times a day in the morning, at noon and at night, and two tablets each time.
Example 7
A preparation method of tablet with hair growth promoting effect from purified dihydromyricetin
And (4) the composition of the tablets is calculated by 1000 tablets.
Composition (A) | Weights (g) |
Dihydromyricetin (purity 98%) | 102 |
Starch | 398 |
(1) Mixing: mixing Ampelopsis Grossdentata powder and starch in a mixer for 10min;
(2) Granulating: granulating by using a dry-method granulator;
(3) Tabletting: tabletting the granulated composition to obtain the tablet with the hair-increasing effect;
the above tablet contains dihydromyricetin 100mg and 0.5g per tablet.
The using method comprises the following steps: twice a day in the morning and at night, two tablets are taken each time with meals.
Example 8
The tablets of the composition obtained in example 3 were evaluated for efficacy
Subject: white hair, partially bald scalp, between the ages of 30-50 years, was selected as 20 individuals at random, 17 men and 3 women.
The experimental method comprises the following steps: by oral administration, the subject takes 2 tablets at a time, 2 times a day in the morning and evening, and 4 tablets a day with meals.
Experiment time: the total test period is 6 months in month.
The evaluation criteria are divided into effective, improving and ineffective, and specifically comprise the following steps:
the effect is shown: stopping alopecia and growing hair again;
improvement: alopecia ceases, with intermittent or mostly long hair;
and (4) invalidation: alopecia is not controlled and continues.
The experimental results are as follows: in 20 cases, the effect is 18 cases, the improvement is 4 cases, and the total effective rate is 100%. The longest apparent time is 2 months, and the shortest one is 1 week.
Typical cases 1: wei Zhi, male 45 years old. Hair loss and hair thinning occur 3 years ago, and the luster of the scalp at the bottom of the hair can be seen, and the tablet is taken 2 times a day with meals and with warm water. After 1 month, hair loss was stopped, after 3 months, new black vellus hairs appeared at the open hair, and the hairs became dense within half a year, and reference was made to a comparison chart shown in fig. 1 before and after taking.
Typical case 2 among them: li Jie, male, 39 years old. After 5 years, the hair loss is increased, the hair in water floats more after washing hair, the hair is increased and decreased in the future, the hair is remained a little, the scalp of a patient is bright, the hair is a little, the hair is shaved by a shaver, the condition of the hair head is kept, after the tablet is taken, the growth of hair vellus hairs is accelerated in one week, and the hair shaving frequency is obviously increased.
Example 9
Evaluation of efficacy of the tablet obtained in example 7
Subjects: white hair, partially bald scalp, between the ages of 30-50 years, was selected as 20 individuals at random, 18 men and 2 women.
The experimental method comprises the following steps: by oral administration, the subject takes 2 tablets at a time, 2 times a day in the morning and evening, and 4 tablets a day with meals.
Experiment time: the total test period is 6 months in months.
The criteria were the same as in example 8.
The experimental results are as follows: of the 20 cases, 12 cases were significant, 5 cases were improved, and 3 cases were ineffective, and the total effective rate was 85%. The longest significant time is 5 months, and the shortest is 3 weeks.
From the efficacy evaluation of examples 8 and 9, when only dihydromyricetin is used as the main component, the hair growth promoting effect is obvious, but after theanine is added, the total effective rate is higher, and the effective time is shorter.
Claims (10)
1. A composition having hair growth enhancing properties, comprising: the composition contains a component A or a component A and a component B, wherein the component A is dihydromyricetin or a plant extract containing dihydromyricetin or powder of a plant containing dihydromyricetin after being crushed, and the component B is theanine or a plant extract containing theanine or powder of a plant containing theanine after being crushed;
the component A and the component B are respectively 10-100 parts of component A and 0-100 parts of component B in parts by mass of dihydromyricetin and theanine.
2. The composition with hair growth promoting effect according to claim 1, characterized in that: the component A and the component B are respectively 50-100 parts of component A and 20-100 parts of component B in parts by mass of dihydromyricetin and theanine.
3. The composition with hair growth promoting effect according to claim 1 or 2, characterized in that: the plant containing dihydromyricetin is Ampelopsis grossedentata or Hovenia dulcis Thunb.
4. The composition with hair growth promoting effect according to claim 3, characterized in that: the plant containing dihydromyricetin is Ampelopsis grossedentata.
5. The composition with hair growth promoting effect according to claim 1 or 2, characterized in that: the plants containing theanine are albino tea, yellow tea, and guard gold tea.
6. The composition with hair growth promoting effect according to claim 5, wherein: the theanine-containing plant is Anji white tea.
7. The composition with hair growth promoting effect according to claim 1 or 2, characterized in that: the composition also comprises pharmaceutically acceptable auxiliary materials.
8. The composition with hair growth promoting effect according to claim 7, characterized in that: the composition is in the form of powder, tablet, capsule, pill, dripping pill, spirit, suspension, aqua, cream, or ointment.
9. The composition with hair growth promoting effect according to claim 8, characterized in that: the composition is a tablet.
10. The composition with hair growth promoting effect of claim 8, wherein: the composition is a capsule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210917373.XA CN115177612A (en) | 2022-08-01 | 2022-08-01 | A composition with hair growth promoting effect |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210917373.XA CN115177612A (en) | 2022-08-01 | 2022-08-01 | A composition with hair growth promoting effect |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115177612A true CN115177612A (en) | 2022-10-14 |
Family
ID=83521151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210917373.XA Pending CN115177612A (en) | 2022-08-01 | 2022-08-01 | A composition with hair growth promoting effect |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115177612A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102742714A (en) * | 2011-04-21 | 2012-10-24 | 北京龙裔生物科技有限公司 | Cigarette addiction eliminating, heart-fire clearing and refreshing chewing gum |
CN104797250A (en) * | 2012-07-13 | 2015-07-22 | 发朵科技公司 | Treating hair loss and delaying aging of skin |
JP2015178485A (en) * | 2014-02-25 | 2015-10-08 | 株式会社コーセー | Hair restoration composition |
WO2022013581A1 (en) * | 2020-07-14 | 2022-01-20 | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. | Nutritional supplement, suitable for oral administration, comprising dihydromyricetin, choline and one or more vitamins with antioxidant activity, for use in the maintenance of normal liver function |
-
2022
- 2022-08-01 CN CN202210917373.XA patent/CN115177612A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102742714A (en) * | 2011-04-21 | 2012-10-24 | 北京龙裔生物科技有限公司 | Cigarette addiction eliminating, heart-fire clearing and refreshing chewing gum |
CN104797250A (en) * | 2012-07-13 | 2015-07-22 | 发朵科技公司 | Treating hair loss and delaying aging of skin |
JP2015178485A (en) * | 2014-02-25 | 2015-10-08 | 株式会社コーセー | Hair restoration composition |
WO2022013581A1 (en) * | 2020-07-14 | 2022-01-20 | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. | Nutritional supplement, suitable for oral administration, comprising dihydromyricetin, choline and one or more vitamins with antioxidant activity, for use in the maintenance of normal liver function |
Non-Patent Citations (1)
Title |
---|
曹敏惠等: "《藤茶二氢杨梅素茶氨酸复合物的制备及抗氧化活性研究》", 《现代食品科技》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102106428B (en) | Compound medlar-jujube and donkey-hide gelatin beautifying tea and preparation method thereof | |
CN107495367B (en) | Food, health-care product or pharmaceutical composition for improving anoxia resistance and preparation method and application thereof | |
CN102165983B (en) | Mixed herb tea | |
CN102389539B (en) | Pure traditional Chinese medicine preparation for removing speckle and beautifying, and preparation method of pulvis and particle of the preparation | |
CN1087267A (en) | A kind of prescription for the treatment of seborrheic alopecia | |
CN110075049B (en) | Traditional Chinese medicine extract and preparation method and application thereof | |
CN101327002A (en) | Health care food for beauty treatment and face nursing | |
KR100800359B1 (en) | A composition having depilation preventing and trichogenousness effect | |
CN102579684A (en) | Chinese medicinal product for clearing intestines and beautifying, and slowing aging | |
CN103446326B (en) | Chinese herbal medicine composition for promoting hair growth and preparation method thereof | |
CN104745419A (en) | Beauty-maintenance and health-maintenance wine | |
CN115177612A (en) | A composition with hair growth promoting effect | |
CN107184519A (en) | A kind of natural Chinese traditional medicines cosmetics and skincare product and its application method | |
CN103735899A (en) | Hypertension injection nursing drug and preparation method thereof | |
CN101224271A (en) | Chinese traditional medicine compounds for treating poliosis | |
CN103479988A (en) | Preparation method for natural composite anti-hair-loss hair-growing liquid for external use | |
CN1159046C (en) | Compounding process of ginseng green Huajing | |
CN104323950A (en) | Natural moisturizing and hydrating cream containing chestnut tree extract | |
CN114848558B (en) | Hair-growing and blackening liquid capable of preventing hair loss and blackening white hair and preparation method thereof | |
CN109200191A (en) | Restrain myogenic, Chinese materia medica preparation of light speckles, beautification and white and preparation method thereof | |
CN108992358A (en) | A kind of U.S. face cream facial mask and preparation method thereof | |
Naman et al. | Anti-Anaemic Potential of Methanolic Leaf Extract of Mucuna Pruriens on Phenylhydrazine (Phz) Induced Anaemic Albino Wistar Rats | |
CN107224572A (en) | A kind of functions of removing chloasma capsule and preparation method thereof | |
CN102727598A (en) | Traditional Chinese medicinal composition for hair blackening and hair regeneration, and preparation method and application thereof | |
CN102488212A (en) | Health food used for improving sleep, and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |